Combining Noxa-Inducing Drugs with ABT-263 to Efficiently Increase Cell Death in Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and neck cancer is the sixth leading cancer worldwide. Head and neck squamous cell carcinoma (HNSCC) accounts for more than 90% of incident cases. Despite intense, multimodality treatment regimens for HNSCC including surgery, chemotherapy, and radiation, little progress has been made over the...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2017
|
| Subjects: | |
| Online Access: | http://scholarscompass.vcu.edu/etd/4847 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=5906&context=etd |